FDA Targets Boosting Adverse Event Review ‘Accuracy And Efficiency’
This article was originally published in The Tan Sheet
Executive Summary
The agency seeks academic institutions and commercial organizations with tools to triage and review post-marketing adverse event drug product case reports submitted to the Adverse Event Reporting System.